Target intelligence / Profile preview

Mitochondrial oxidative phosphorylation system (OXPHOS) (OXPHOS)

Target
OXPHOS
Molecular classification
Enzyme, Transporter, Protein complex
01

Overview

The mitochondrial oxidative phosphorylation (OXPHOS) system is the primary energy-generating machinery in eukaryotic cells, consisting of five multi-subunit protein complexes (Complexes I-V) located in the inner mitochondrial membrane (StatPearls, 2023). It couples the transfer of electrons from electron donors (NADH and FADH2) to oxygen with the pumping of protons to create an electrochemical gradient, which ultimately drives the synthesis of ATP by ATP synthase (NCBI, 2022). Beyond energy production, this machinery plays critical roles in regulating cellular redox state, reactive oxygen species (ROS) signaling, and the initiation of apoptosis (Nature Reviews Molecular Cell Biology, 2020). Dysregulation of OXPHOS is implicated in a wide range of pathologies, including primary mitochondrial disorders, neurodegenerative diseases like Parkinson's, and metabolic syndromes (PubMed, 2021). In oncology, certain cancers exhibit a high dependency on OXPHOS, making specific components like Complex I attractive therapeutic targets for small-molecule inhibitors such as IACS-010759 (Nature Medicine, 2018). However, targeting these enzymes requires careful management of systemic toxicity, as they are essential for the function of high-energy-demand organs like the heart and brain (Journal of Clinical Investigation, 2017).

Other names
Electron transport chainRespiratory chainMitochondrial respiratory chainMitochondrial respiratory chain complexes
02

Mechanism of action

Inhibition of electron transport chain complexes (I-IV), uncoupling of oxidative phosphorylation, and inhibition of ATP synthase (Complex V) to modulate cellular energy levels and redox state.

03

Biological functions

ATP synthesisCellular respirationRedox homeostasisApoptosisReactive oxygen species production
04

Disease associations

Mitochondrial diseaseCancerNeurodegenerative diseaseCardiovascular diseaseMetabolic disorder
05

Safety considerations

Lactic acidosisSystemic toxicityNeurotoxicityCardiotoxicityNarrow therapeutic window
06

Interacting drugs

Metformin

9 more in the full profile.

07

Biomarkers

LactateOxygen consumption rate (OCR)Fibroblast growth factor 21 (FGF-21)Growth differentiation factor 15 (GDF-15)Mitochondrial DNA copy number

Beyond the preview

Go deeper on Mitochondrial oxidative phosphorylation system (OXPHOS) (OXPHOS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial oxidative phosphorylation system (OXPHOS) (OXPHOS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call